SearchDictionaryMobileLogin

Street Drugs (Illicit Drugs)

930  relevant articles (7 outcomes, 90 trials/studies) found for this Bio-Agent

Description: Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.

Also Known As:
Illicit Drugs; Recreational Drugs; Drugs of Abuse; Drugs, Recreational; Abuse Drugs; Drugs, Illicit; Drugs, Street

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Araújo, João R: 1 article (08/2008)
2. Gonçalves, Pedro: 1 article (08/2008)
3. Martel, Fátima: 1 article (08/2008)
4. Brust, John C M: 1 article (07/2008)
5. Brender, Jean D: 1 article (05/2008)
6. Suarez, Lucina: 1 article (05/2008)
7. Hendricks, Kate: 1 article (05/2008)
8. Canfield, Mark: 1 article (05/2008)
9. Felkner, Marilyn: 1 article (05/2008)
10. Jacobs, Frédéric: 1 article (04/2008)

Related Diseases

1. Substance-Related Disorders (Drug Abuse)
04/01/2000 - "Because, to our knowledge, no other intervention has successfully altered substance abuse by athletes, we developed and assessed the efficacy of a team-centered, sex-specific education program designed to reduce adolescent athletes' intentions to use and use of AS and alcohol and other illicit drugs. "
03/01/2004 - "The purpose of this article is (a) to review studies that have examined the relationship of drug abuse and child neglect, (b) to review clinical treatments that appear to be effective in both perpetrators of child neglect and drug-abusing adolescents, and (c) to integrate empirically validated drug abuse and child neglect interventions for use in adolescent mothers who have been found to abuse drugs and neglect their children."
01/01/2008 - "Although individuals who use illicit drugs are a potentially vulnerable population, there have been no objective evaluations of the effectiveness of standard informed consent procedures in assuring that prospective participants entering drug abuse treatment trials fully understand the nature of the research and treatments in which they have agreed to participate. "
03/15/2006 - "These results suggest that the mouse model of relapse in our study might provide a new stage for the exploration of genetic factors involved in relapse of drug dependence and of the underlying mechanisms of drugs of abuse."
01/01/2006 - "As these may underlie drug dependence and addiction, the purpose of the present study was to examine if different drugs of abuse effect changes in gene expression that converge in common molecular pathways. "
Order ALL the reference details at left...
2. Alcoholism (Alcohol Abuse)
3. Schizophrenia (Dementia Praecox)
11/01/2006 - "Although the proof of efficacy of pharmacotherapeutic agents is to be derived ultimately from clinical trials, the preclinical findings that selective antagonism at DA D(3) receptors reduces the reinforcing efficacy of drugs of abuse, reverses cognitive deficits, and shows efficacy in animal models of schizophrenia add to an accumulating body of evidence that selective DA D(3) receptor antagonists may hold highest promise in the treatment of several neuropsychiatric diseases. "
12/01/2006 - "Data from 5 large schizophrenia studies that included the MASC were examined: a study of victimization in women who abuse drugs, a study of health care among people with diabetes, a study of vocational outcomes, a study of social skill among drug abusers, and a clinical trial comparing two antipsychotic medications. "
01/01/2001 - "This study examined how illicit drugs were accessed, reasons for drug use, prevalence of emotional, physical, and sexual abuse, psychiatric symptomatology, level of functioning, and the relationship of these factors to substance use in 25 schizophrenia outpatients. "
01/01/1989 - "Fifty-eight percent of young adult clients with clearly defined schizophrenia or schizophrenia-related disorders participating in a long-term community treatment study were rated by staff or themselves as using alcohol, cannabis, or other street drugs several times a week or more. "
11/01/2009 - "Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia."
Order ALL the reference details at left...
4. Mental Disorders (Mental Disorder)
5. Pain (Aches)

Related Drugs and Biologics

1. Cocaine (Cocaine HCl)
2. Methamphetamine (Desoxyn)
3. Nicotine
4. kappa Opioid Receptors (kappa Opioid Receptor)
5. Heroin (Diamorphine)
6. Opioid Analgesics (Opioids)
7. Hormones
8. Opioid Peptides (Opioid Peptide)
9. Amphetamine (Amfetamine)
10. Smoke

Related Therapies and Procedures

1. Analgesia
2. Prenatal Care
3. Self Administration (Administration, Self)
4. Length of Stay
5. Tracheotomy

Best Treatments:
Research Summary Report
on Substance-Related Disorders

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 194 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>